Selected research
Market Analysis & Forecast
Global Canine Biopsy Services Market Analysis and Forecast 2026-2032
Market perspective
The global Canine Biopsy Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Canine Biopsy Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Canine Biopsy Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Canine Biopsy Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Canine Biopsy Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Canine Biopsy Services include Small Door, ANGLE, BioChain Institute Inc., CANCAN DIAGNOSTICS., PetDx, CYTOGEN and BioChain, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Canine Biopsy Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Canine Biopsy Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Canine Biopsy Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Canine Biopsy Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Canine Biopsy Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Canine Biopsy Services revenue, projected growth trends, production technology, application and end-user industry.
Canine Biopsy Services Segment by Company
Small Door
ANGLE
BioChain Institute Inc.
CANCAN DIAGNOSTICS.
PetDx
CYTOGEN
BioChain
Canine Biopsy Services Segment by Type
Cut Biopsy
Needle Biopsy
Canine Biopsy Services Segment by Application
Pet Hospital
Clinic
Canine Biopsy Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Canine Biopsy Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Canine Biopsy Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Canine Biopsy Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Canine Biopsy Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Canine Biopsy Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Canine Biopsy Services revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cut Biopsy
- Needle Biopsy
Applications
- Pet Hospital
- Clinic
Companies covered
- Small Door
- ANGLE
- BioChain Institute Inc.
- CANCAN DIAGNOSTICS.
- PetDx
- CYTOGEN
- BioChain
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Canine Biopsy Services Market by Type
- 1.2.1 Global Canine Biopsy Services Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Cut Biopsy
- 1.2.3 Needle Biopsy
- 1.3 Canine Biopsy Services Market by Application
- 1.3.1 Global Canine Biopsy Services Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Pet Hospital
- 1.3.3 Clinic
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Canine Biopsy Services Market Dynamics
- 2.1 Canine Biopsy Services Industry Trends
- 2.2 Canine Biopsy Services Industry Drivers
- 2.3 Canine Biopsy Services Industry Opportunities and Challenges
- 2.4 Canine Biopsy Services Industry Restraints
3 Global Growth Perspective
- 3.1 Global Canine Biopsy Services Market Perspective (2021-2032)
- 3.2 Global Canine Biopsy Services Growth Trends by Region
- 3.2.1 Global Canine Biopsy Services Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Canine Biopsy Services Market Size by Region (2021-2026)
- 3.2.3 Global Canine Biopsy Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Canine Biopsy Services Revenue by Players
- 4.1.1 Global Canine Biopsy Services Revenue by Players (2021-2026)
- 4.1.2 Global Canine Biopsy Services Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Canine Biopsy Services Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Canine Biopsy Services Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Canine Biopsy Services Key Players Headquarters & Area Served
- 4.4 Global Canine Biopsy Services Players, Product Type & Application
- 4.5 Global Canine Biopsy Services Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Canine Biopsy Services Market CR5 and HHI
- 4.6.3 2025 Canine Biopsy Services Tier 1, Tier 2, and Tier 3
5 Canine Biopsy Services Market Size by Type
- 5.1 Global Canine Biopsy Services Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Canine Biopsy Services Revenue by Type (2021-2032)
- 5.3 Global Canine Biopsy Services Revenue Market Share by Type (2021-2032)
6 Canine Biopsy Services Market Size by Application
- 6.1 Global Canine Biopsy Services Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Canine Biopsy Services Revenue by Application (2021-2032)
- 6.3 Global Canine Biopsy Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Small Door
- 7.1.1 Small Door Company Information
- 7.1.2 Small Door Business Overview
- 7.1.3 Small Door Canine Biopsy Services Revenue and Gross Margin (2021-2026)
- 7.1.4 Small Door Canine Biopsy Services Product Portfolio
- 7.1.5 Small Door Recent Developments
- 7.2 ANGLE
- 7.2.1 ANGLE Company Information
- 7.2.2 ANGLE Business Overview
- 7.2.3 ANGLE Canine Biopsy Services Revenue and Gross Margin (2021-2026)
- 7.2.4 ANGLE Canine Biopsy Services Product Portfolio
- 7.2.5 ANGLE Recent Developments
- 7.3 BioChain Institute Inc.
- 7.3.1 BioChain Institute Inc. Company Information
- 7.3.2 BioChain Institute Inc. Business Overview
- 7.3.3 BioChain Institute Inc. Canine Biopsy Services Revenue and Gross Margin (2021-2026)
- 7.3.4 BioChain Institute Inc. Canine Biopsy Services Product Portfolio
- 7.3.5 BioChain Institute Inc. Recent Developments
- 7.4 CANCAN DIAGNOSTICS.
- 7.4.1 CANCAN DIAGNOSTICS. Company Information
- 7.4.2 CANCAN DIAGNOSTICS. Business Overview
- 7.4.3 CANCAN DIAGNOSTICS. Canine Biopsy Services Revenue and Gross Margin (2021-2026)
- 7.4.4 CANCAN DIAGNOSTICS. Canine Biopsy Services Product Portfolio
- 7.4.5 CANCAN DIAGNOSTICS. Recent Developments
- 7.5 PetDx
- 7.5.1 PetDx Company Information
- 7.5.2 PetDx Business Overview
- 7.5.3 PetDx Canine Biopsy Services Revenue and Gross Margin (2021-2026)
- 7.5.4 PetDx Canine Biopsy Services Product Portfolio
- 7.5.5 PetDx Recent Developments
- 7.6 CYTOGEN
- 7.6.1 CYTOGEN Company Information
- 7.6.2 CYTOGEN Business Overview
- 7.6.3 CYTOGEN Canine Biopsy Services Revenue and Gross Margin (2021-2026)
- 7.6.4 CYTOGEN Canine Biopsy Services Product Portfolio
- 7.6.5 CYTOGEN Recent Developments
- 7.7 BioChain
- 7.7.1 BioChain Company Information
- 7.7.2 BioChain Business Overview
- 7.7.3 BioChain Canine Biopsy Services Revenue and Gross Margin (2021-2026)
- 7.7.4 BioChain Canine Biopsy Services Product Portfolio
- 7.7.5 BioChain Recent Developments
8 North America
- 8.1 North America Canine Biopsy Services Revenue (2021-2032)
- 8.2 North America Canine Biopsy Services Revenue by Type (2021-2032)
- 8.2.1 North America Canine Biopsy Services Revenue by Type (2021-2026)
- 8.2.2 North America Canine Biopsy Services Revenue by Type (2027-2032)
- 8.3 North America Canine Biopsy Services Revenue Share by Type (2021-2032)
- 8.4 North America Canine Biopsy Services Revenue by Application (2021-2032)
- 8.4.1 North America Canine Biopsy Services Revenue by Application (2021-2026)
- 8.4.2 North America Canine Biopsy Services Revenue by Application (2027-2032)
- 8.5 North America Canine Biopsy Services Revenue Share by Application (2021-2032)
- 8.6 North America Canine Biopsy Services Revenue by Country
- 8.6.1 North America Canine Biopsy Services Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Canine Biopsy Services Revenue by Country (2021-2026)
- 8.6.3 North America Canine Biopsy Services Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Canine Biopsy Services Revenue (2021-2032)
- 9.2 Europe Canine Biopsy Services Revenue by Type (2021-2032)
- 9.2.1 Europe Canine Biopsy Services Revenue by Type (2021-2026)
- 9.2.2 Europe Canine Biopsy Services Revenue by Type (2027-2032)
- 9.3 Europe Canine Biopsy Services Revenue Share by Type (2021-2032)
- 9.4 Europe Canine Biopsy Services Revenue by Application (2021-2032)
- 9.4.1 Europe Canine Biopsy Services Revenue by Application (2021-2026)
- 9.4.2 Europe Canine Biopsy Services Revenue by Application (2027-2032)
- 9.5 Europe Canine Biopsy Services Revenue Share by Application (2021-2032)
- 9.6 Europe Canine Biopsy Services Revenue by Country
- 9.6.1 Europe Canine Biopsy Services Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Canine Biopsy Services Revenue by Country (2021-2026)
- 9.6.3 Europe Canine Biopsy Services Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Canine Biopsy Services Revenue (2021-2032)
- 10.2 China Canine Biopsy Services Revenue by Type (2021-2032)
- 10.2.1 China Canine Biopsy Services Revenue by Type (2021-2026)
- 10.2.2 China Canine Biopsy Services Revenue by Type (2027-2032)
- 10.3 China Canine Biopsy Services Revenue Share by Type (2021-2032)
- 10.4 China Canine Biopsy Services Revenue by Application (2021-2032)
- 10.4.1 China Canine Biopsy Services Revenue by Application (2021-2026)
- 10.4.2 China Canine Biopsy Services Revenue by Application (2027-2032)
- 10.5 China Canine Biopsy Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Canine Biopsy Services Revenue (2021-2032)
- 11.2 Asia Canine Biopsy Services Revenue by Type (2021-2032)
- 11.2.1 Asia Canine Biopsy Services Revenue by Type (2021-2026)
- 11.2.2 Asia Canine Biopsy Services Revenue by Type (2027-2032)
- 11.3 Asia Canine Biopsy Services Revenue Share by Type (2021-2032)
- 11.4 Asia Canine Biopsy Services Revenue by Application (2021-2032)
- 11.4.1 Asia Canine Biopsy Services Revenue by Application (2021-2026)
- 11.4.2 Asia Canine Biopsy Services Revenue by Application (2027-2032)
- 11.5 Asia Canine Biopsy Services Revenue Share by Application (2021-2032)
- 11.6 Asia Canine Biopsy Services Revenue by Country
- 11.6.1 Asia Canine Biopsy Services Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Canine Biopsy Services Revenue by Country (2021-2026)
- 11.6.3 Asia Canine Biopsy Services Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Canine Biopsy Services Revenue (2021-2032)
- 12.2 SAMEA Canine Biopsy Services Revenue by Type (2021-2032)
- 12.2.1 SAMEA Canine Biopsy Services Revenue by Type (2021-2026)
- 12.2.2 SAMEA Canine Biopsy Services Revenue by Type (2027-2032)
- 12.3 SAMEA Canine Biopsy Services Revenue Share by Type (2021-2032)
- 12.4 SAMEA Canine Biopsy Services Revenue by Application (2021-2032)
- 12.4.1 SAMEA Canine Biopsy Services Revenue by Application (2021-2026)
- 12.4.2 SAMEA Canine Biopsy Services Revenue by Application (2027-2032)
- 12.5 SAMEA Canine Biopsy Services Revenue Share by Application (2021-2032)
- 12.6 SAMEA Canine Biopsy Services Revenue by Country
- 12.6.1 SAMEA Canine Biopsy Services Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Canine Biopsy Services Revenue by Country (2021-2026)
- 12.6.3 SAMEA Canine Biopsy Services Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst